Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Lancet Regional Health. Americas|March 19, 2024
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort studyNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.
Open Forum Infectious Diseases|February 12, 2021
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal AgentsMatthew A Miller, Kyle C Molina, Jonathan A Gutman, et al.
Open Forum Infectious Diseases|July 2, 2025
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19Joshua P Havens, Nayon Kang, Lucy Chung, et al.
BMC Infectious Diseases|May 26, 2026
Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infectionsMohammed Al Musawa, Amer El Ghali, Taylor Morrisette, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Open Forum Infectious Diseases|August 25, 2021
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomesAmer El Ghali, Taylor Morrisette, Sara Alosaimy, et al.
Pageof 6